百奥泰跌3.95% 2020年上市即巅峰募19.7亿

Summary of Key Points Core Viewpoint - Baiotai (688177.SH) has experienced a decline in stock price, closing at 23.82 yuan with a drop of 3.95%, indicating a state of breaking down [1]. Company Overview - Baiotai was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on February 21, 2020, with an initial offering price of 32.76 yuan per share [1]. - The company issued 60 million shares during its IPO, with China International Capital Corporation serving as the sponsor and representatives being Xie Xianming and Zhao Zeyu, while GF Securities and Morgan Stanley Huaxin Securities acted as joint underwriters [1]. IPO Financials - The total funds raised from the IPO amounted to 1.966 billion yuan, with a net amount of 1.876 billion yuan after deducting issuance costs [1]. - The final net fundraising amount was 124 million yuan less than the original plan of 2 billion yuan, which was intended for drug research and development, marketing network construction, and working capital supplementation [1]. - The total issuance costs for the IPO were 89.4002 million yuan, with 77.8302 million yuan paid to the sponsor and joint underwriters for underwriting and sponsorship fees [1]. Stock Performance - On the first day of trading, Baiotai reached an intraday high of 78.00 yuan per share, reflecting strong initial market interest [1].